Scott Bizily, Chief Legal Officer: 4D Molecular Therapeutics FDMT Sell · Filed 25/11/19

Trade details

Type: Insider sale
Amount: $17,314.65
Shares · price: 1,635 sh · $10.59 a share
Held after: 3,594 sh
Stock: 4D Molecular Therapeutics FDMT
Person: Scott BizilyChief Legal Officer
Trade date: 25/11/17
Filed: 25/11/19
Days to filing: 2 days

Sold 31.3% of holdings

Share of holding sold: 31.3%

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Scott Bizily's recent trades

Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$79.7K
6,540 sh
$79.7K
Filed 08/17
Traded 08/17
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$19.4K
1,635 sh
$19.4K
Filed 08/13
Traded 08/13
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$84.6K
6,566 sh
$84.6K
Filed 06/30
Traded 06/30
Scott BizilyChief Legal Officer
Sell10b5-1 plan4D Molecular Therapeutics
Sell10b5-1 plan
4D Molecular Therapeutics
FDMT
$117.7K
9,810 sh
$117.7K
Filed 06/25
Traded 06/23
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$102.2K
9,810 sh
$102.2K
Filed 06/23
Traded 06/23